Lexaria raises $7.9M, extends cash runway through 2027

Go back to Lexaria raises $7.9M, extends cash runway through 2027

Lexaria Updates Financial Position

September 17, 2026 9:10 AM EDT

KELOWNA, BC / ACCESS Newswire / September 17, 2026 / Lexaria Bioscience Corp. (NASDAQ: LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is providing the following update.

Lexaria is in a strong cash position following both its recently announced Australian tax refund and recent institutional financing priced at US$12.92/share. The combined net proceeds from these two items totaled US$7.9 million. With only 2.1 million shares currently issued and... More